BIO-key International (NASDAQ:BKYI – Get Free Report) is projected to announce its Q3 2026 results on Friday, November 13th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $2.40 million for the quarter. Interested persons may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Friday, November 13, 2026 at 10:00 AM ET.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.82) by $0.26. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. The business had revenue of $1.92 million for the quarter, compared to the consensus estimate of $1.80 million. On average, analysts expect BIO-key International to post ($1.62) EPS for the current fiscal year and $0.22 EPS for the next fiscal year.
BIO-key International Trading Up 5.1%
Shares of BKYI opened at $2.48 on Thursday. BIO-key International has a 12 month low of $1.55 and a 12 month high of $11.10. The stock has a fifty day moving average price of $2.48 and a 200-day moving average price of $4.43.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on BKYI. Wall Street Zen raised BIO-key International to a “hold” rating in a research report on Saturday, October 24th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. Finally, Zacks Research raised BIO-key International to a “hold” rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, BIO-key International presently has a consensus rating of “Reduce”.
Read Our Latest Stock Report on BIO-key International
About BIO-key International
BIO-key International, Inc. (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords. Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.
Featured Stories
- Five stocks we like better than BIO-key International
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
